Albumin influences leucocyte FcRn expression in the early days of kidney transplantation.
Pierre BoulardNicolas AzzopardiRomain LevardJean-Marie CornecJuliette LamamyBérénice PrieurMarie-Véronique DematteiHervé WatierPhilippe GataultValérie Gouilleux-GruartPublished in: Clinical and experimental immunology (2024)
FcRn, a receptor originally known for its involvement in IgG and albumin transcytosis and recycling, is also important in the establishment of the innate and adaptive immune response. Dysregulation of the immune response has been associated with variations in FcRn expression, as observed in cancer. Recently, a link between autophagy and FcRn expression has been demonstrated. Knowing that autophagy is strongly involved in the development of reperfusion injury in kidney transplantation and that albuminemia is transiently decreased in the first 2 weeks after transplantation, we investigated variations in FcRn expression after kidney transplantation. We monitored FcRn levels by flow cytometry in leukocytes from 25 renal transplant patients and considered parameters such as albumin concentrations, estimated glomerular filtration rate, serum creatinine, serum IgG levels, and ischaemia/reperfusion time. Two groups of patients could be distinguished according to their increased or non-increased FcRn expression levels between days 2 and 6 (d2-d6) post-transplantation. Leukocyte FcRn expression at d2-d6 was correlated with albumin concentrations at d0-d2. These results suggest that albumin concentrations at d0-d2 influence FcRn expression at d2-d6, raising new questions about the mechanisms underlying these original observations.
Keyphrases
- poor prognosis
- immune response
- kidney transplantation
- end stage renal disease
- binding protein
- ejection fraction
- newly diagnosed
- cell death
- chronic kidney disease
- heart failure
- acute myocardial infarction
- flow cytometry
- long non coding rna
- oxidative stress
- endoplasmic reticulum stress
- prognostic factors
- signaling pathway
- toll like receptor
- inflammatory response
- mass spectrometry
- left ventricular
- cell therapy
- lymph node metastasis